Replies to post #2689 on Ariad Pharmaceuticals Inc fka ARIA

[BTH]

Yes...

A protocol amendment added chemotherapy as a control; however, these patients (n=2) were not included in this unplanned interim analysis. The primary endpoint was progression free survival (PFS).

Results: As of March 24, 2010, 87 of 150 patients had been randomized—44 and 41 treated with R and P, respectively.